NSC |
Compound |
Enrichment |
Correlation |
NSC 693563 |
Null |
0.0306776553926119 |
0.2793488 |
NSC 699767 |
Null |
0.0306776553926119 |
0.17083027 |
NSC 707465 |
2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- |
0.0306776553926119 |
0.20964072 |
NSC 710779 |
Null |
0.0306776553926119 |
0.28687343 |
NSC 724780 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 |
0.0306776553926119 |
0.37597984 |
NSC 728040 |
2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline |
0.0306776553926119 |
0.37711642 |
NSC 728132 |
1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene |
0.0306776553926119 |
0.24824126 |
NSC 736079 |
4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine |
0.0306776553926119 |
0.41077358 |
NSC 736081 |
4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine |
0.0306776553926119 |
0.27043839 |
NSC 736153 |
Null |
0.0306776553926119 |
0.39087562 |